Isoliquiritigenin regulates the circ_0002860/miR-431-5p/RAB9A axis to function as a tumor inhibitor in melanoma
Authors:
Open Access
- 1 January 2023
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Journal of Venomous Animals and Toxins including Tropical Diseases
- Vol. 29, e20220019
Abstract
Isoliquiritigenin (ISL) presents antitumor effects against melanoma cells. It is known that various circular RNAs (circRNAs) are involved in the development of melanoma. Therefore, the present study aims to investigate the molecular mechanisms of ISL and circ_0002860. Circ_0002860, microRNA-431-5p (miR-431-5p) and member RAS oncogene family (RAB9A) were detected through reverse transcription-quantitative polymerase chain reaction (RT-qPCR) assay. Cell viability was examined via cell counting kit-8 assay. The proliferation ability was assessed using colony formation assay. Cell apoptosis and cell cycle were determined by flow cytometry. Transwell assay was used for detection of migration and invasion. Western blot was conducted for protein analysis. Target binding was confirmed via dual-luciferase reporter assay and RNA immunoprecipitation (RIP) assay. In vivo research was performed through xenograft tumor assay. Circ_0002860 was downregulated by ISL in melanoma cells. ISL-induced inhibitory effects on cell proliferation, cell cycle progression, migration and invasion were alleviated by circ_0002860 overexpression. MiR-431-5p was a target of circ_0002860. Circ_0002860 eliminated the ISL-induced tumor inhibition via sponging miR-431-5p in melanoma cells. Circ_0002860 elevated the RAB9A level by targeting miR-431-5p. The function of ISL was related to miR-431-5p/RAB9A axis in melanoma progression. Tumor growth was reduced by ISL in vivo through downregulating circ_0002860 to regulate miR-431-5p and RAB9A levels. The current data indicates that ISL suppressed cell malignant progression of melanoma via targeting the circ_0002860/miR-431-5p/RAB9A pathway.Keywords
This publication has 28 references indexed in Scilit:
- Isoliquiritigenin (ISL) and its Formulations: Potential Antitumor AgentsCurrent Medicinal Chemistry, 2019
- Long noncoding RNA ZFAS1 promotes tumorigenesis through regulation of miR-150-5p/RAB9A in melanomaMelanoma Research, 2019
- Isoliquiritigenin suppresses the proliferation and induced apoptosis via miR-32/LATS2/Wnt in nasopharyngeal carcinomaEuropean Journal of Pharmacology, 2019
- Circular RNAs Act as miRNA Sponges2018
- Circular RNA Splicing2018
- Isoliquiritigenin suppresses human melanoma growth by targeting miR-301b/LRIG1 signalingJournal of Experimental & Clinical Cancer Research, 2018
- circRNA_0084043 promote malignant melanoma progression via miR-153-3p/Snail axisBiochemical and Biophysical Research Communications, 2018
- Isoliquiritigenin modulates miR-374a/PTEN/Akt axis to suppress breast cancer tumorigenesis and metastasisScientific Reports, 2017
- A Review: The Pharmacology of IsoliquiritigeninPhytotherapy Research, 2015
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001